ENANTA PHARMACEUTICALS INC (ENTA) Revenue 2016–2025
ENANTA PHARMACEUTICALS INC (ENTA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$65.3MFY2025 · since FY2016: $88.3M → $65.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $65.3M | -3.4% |
| FY2024 | $67.6M | -14.6% |
| FY2023 | $79.2M | -8.1% |
| FY2022 | $86.2M | -11.2% |
| FY2021 | $97.1M | -20.7% |
| FY2020 | $122.5M | -40.3% |
| FY2019 | $205.2M | -0.7% |
| FY2018 | $206.6M | +101.0% |
| FY2017 | $102.8M | +16.5% |
| FY2016 | $88.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice